MAIA Biotechnology, Inc. Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

3 Months Ended

Mar. 31, 2024

3. ACCRUED EXPENSES

As of March 31, 2024 and December 31, 2023 accrued expenses consisted of the following:


	March 31,		December 31,
	2024		2023
Bonus	$	1,006,187	$	786,999
Professional fees		175,910		77,942
Research and development costs		989,847		998,838
Accrued severance		603,635		824,435
Other		259,686		610,393
Total accrued expenses	$	3,035,265	$	3,298,607